Standard Biotools (LAB) Net Income (2010 - 2026)

Standard Biotools (LAB) has 17 years of Net Income data on file, last reported at $141.7 million in Q1 2026.

• On a quarterly basis, Net Income rose 5420.84% year-over-year to $141.7 million in Q1 2026; TTM through Mar 2026 was $128.3 million, a 468.06% increase from a year earlier, with the FY2025 full-year figure at -$16.1 million, up 66.48% from the prior year.
• Net Income for Q1 2026 stood at $141.7 million, up from $5.4 million in the prior quarter.
• Over the last five years, Net Income for LAB reached as high as $153.2 million in Q4 2022 and fell as low as -$76.3 million in Q1 2022.
• Historically, Net Income has averaged $260588.2 across 5 years, with a median of -$15.8 million in 2025.
• Across the five-year window, Net Income sank 305.96% in 2022 and jumped 5420.84% in 2026, its largest moves.
• Year by year, Net Income stood at $153.2 million in 2022, then tumbled by 90.78% to $14.1 million in 2023, then tumbled by 148.84% to -$6.9 million in 2024, then soared by 178.01% to $5.4 million in 2025, then soared by 2532.74% to $141.7 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were $141.7 million in Q1 2026, $5.4 million in Q4 2025, and -$3.0 million in Q3 2025.